| Autor: |
Seyam RM; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. rmseyam@yahoo.com., Zeitouni OM; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia., Alsibai TM; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia., AlAyoub AJ; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia., Al-Qassab OM; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia., AlDeiry MA; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia., Zino AO; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia., Hulwi HS; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia., Mokhtar AA; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Shahbaz M; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Junejo NN; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Alotaibi MF; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Alzahrani HM; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Alothman KI; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Alkhateeb SS; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Al-Hussain TO; Department of Pathology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Altaweel WM; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. |
| Abstrakt: |
Flexible cystoscopy under local anaesthesia is standard for the surveillance of bladder cancer. Frequently, several reusable cystoscopes fail to reprocess. With the new grasper incorporated single-use cystoscope for retrieval of ureteric stents, we explored the feasibility of using it off-label for diagnosis and the detection of bladder cancer. Consecutive diagnostic flexible cystoscopies between Mar 2016 and Nov 2018 were reviewed comparing the reusable versus the disposable cystoscopes. A total of 390 patients underwent 1211 cystoscopies. Median age was 61.5 years (SD 14.2, 18.8-91.4), males 331 (84.9%) and females 59 (15.1%). Indication for cystoscopy was prior malignancy in 1183 procedures (97.7%), haematuria 19 (1.6%) or bladder mass 7 (0.6%). There were 608 reusable and 603 disposable cystoscopies. There was no significant difference between groups at baseline in age, sex, BMI, smoking status, or prior tumor risk category. There was no significant difference in positive findings (123/608, 20.2% vs 111/603, 18.4%, p = 0.425) or cancer detection rates (95/608, 15.6% vs 88/603, 14.4%, p 0.574) among the two groups, respectively. We conclude that the disposable grasper integrated cystoscope is comparable to reusable cystoscope in the detection of bladder cancer. |
